PRELIMINARY CYTOTOXIC EVALUATION OF Andrographis paniculata IN BREAST CANCER CELL LINES
Main Article Content
Abstract
Sambiloto (Andrographis paniculata) is widely used as medicine to treat various diseases in Indonesia and other Asian countries. In this study, methanolic and ethanolic extracts of sambiloto collected from B2PTO Tawangmangu have been tested againts breast cancer cell lines of T47D and MCF-7 and normal fibroblast cell line of HFL-1 using enzymatic reaction of 3-(4,5-dimethylthiazoyl-2-yl) 2,5-diphenyltetrazoliumbromide (MTT). In vitro assay performed on normal fibroblast of HFL-1 cell line showed that 50 ppm of methanolic extract of sambiloto did not inhibit cell growth. However, methanolic and ethanolic extracts of sambiloto gave relatively low of IC50 on breast cancer cell lines which were 111 ppm and 122 ppm on the MCF-7 cell lines and 70 ppm and 197 ppm on the T47D cell lines, respectively. In addition, the mixture of sambiloto extract containing 25% of Thyponium divaricatum and Anredera cordifolia extracts confered greater growth inhibition on breast cancer cell line of MCF-7, where IC50 values were 68 ppm and 34 ppm, respectively. In conclusion, the total methanolic or ethanolic extract of sambiloto collected from Tawangmangu has potency as a source of anti-cancer compounds and needs further study.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
a). Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial-ShareAlike 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b). Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
References
Gopalkrishnan A, Rao MV (2008) Suppression of arsenic-provoked toxicity by Andrographis paniculata leaf extract. Asian J Tradit Med 3:104-109
Jarukamjorn K, Nemoto N (2008) Pharmacological Aspects of Andrographis paniculata on Health and Its Major Diterpenoid Constituent Andrographolide. J Health Sci 54:370-381
Kumar RA, Sridevi K, Kumar NV, Nanduri S, Rajagopal S (2004) Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol 92:291–295
Ojha SK, Nandave M, Kumari S, Arya DS (2009) Antioxidant Activity of Andrographis paniculata in Ischemic Myocardium of Rats. Global J Pharmacol 3:154-157
Rao NK (2006) Anti-hyperglycemic and renal protective activities of Andrographis paniculata roots chloroform extract. Jordan J Pharmacol Terapeutic 5:47-50
Sule A, Ahmed QU, Samah OA, Omar MN (2010) Screening for Antibacterial Activity of Andrographis paniculata Used in Malaysian Folkloric Medicine: A Possible Alternative for the Treatment of Skin Infections. Ethnobot Leaflets 2010:8
Wibudi A, Kiranadi B, Manalu W, Winarto A, Suyono S (2008) The Traditional Plant, Andrographis paniculata (Sambiloto) Exhibits Insulin-Releasing Actions in Vitro. Acta Med Indones-Indones J Intern Med 40:63-68
Zhang XQ, Wang GC, Ye WC, Li Q, Zhou GX, Yao XS (2006) New diterpenoids from Andrographis paniculata (Burm. f.) Nees. J Integr Plant Biol 48:1122−1125